#Biotech/Cannabinoid
Stock News: Scythian Biosciences Corp. (TSXV: $SCYB.V) Appoints Former VP of (
$CELG) as Chief Scientific Officer
Former
Vice President of the Chiral Pharmaceutical Business Unit at Celgene
Corporation (NASDAQ: $CELG) Joins Scythian Biosciences
TORONTO
- September 13, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp.
(the "Company") (TSXV: SCYB) reports that
Maghsoud Dariani has become the Chief Scientific Officer of the Company. Mr.
Dariani was previously on the Company's advisory board and has over 35 years of
experience in the development and commercialization of products in the
pharmaceutical industry. Mr. Dariani's experience includes, among other things,
management positions at Semorex, Focus Pharmaceuticals, Celgene and Chiral
Pharmaceuticals.
Read this news in
full at http://www.investorideas.com/CO/SCYB/news/2017/09131CELG.asp
is
a Featured biotech and marijuana company on Investorideas.com
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian
Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis
Investor Ideas Directory and is a paid featured cannabis company and biotech
for news, social media and PR effective August 7th for 2 months. More details
- http://www.investorideas.com/About/News/Clientspecifics.asp
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors
must adhere to regulations of each country